Cellectis SA (CLLS)
0.9202
-0.12
(-11.52%)
USD |
NASDAQ |
Oct 19, 16:00
0.9202
0.00 (0.00%)
After-Hours: 16:14
Cellectis Cash from Operations (Annual) : -40.14M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -40.14M |
| December 31, 2024 | 22.10M |
| December 31, 2023 | -25.08M |
| December 31, 2022 | -87.78M |
| December 31, 2021 | -104.77M |
| December 31, 2020 | -80.26M |
| December 31, 2019 | -69.14M |
| December 31, 2018 | -68.14M |
| December 31, 2017 | -52.87M |
| December 31, 2016 | -32.70M |
| December 31, 2015 | 3.588M |
| December 31, 2014 | 55.35M |
| Date | Value |
|---|---|
| December 31, 2013 | -25.03M |
| December 31, 2012 | -25.36M |
| December 31, 2011 | -14.15M |
| December 31, 2010 | -21.00M |
| December 31, 2009 | -4.615M |
| December 31, 2008 | 2.095M |
| December 31, 2007 | -5.278M |
| December 31, 2006 | -2.875M |
| December 31, 2005 | 0.4857M |
| December 31, 2004 | -2.962M |
| December 31, 2003 | -2.878M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| DBV Technologies SA | -121.56M |
| Akari Therapeutics Plc | -10.59M |
| Bicycle Therapeutics Plc | -250.26M |
| EDAP TMS SA | -- |
| argenx SE | 850.49M |